eFFECTOR Therapeutics (EFTR) Revenue & Revenue Breakdown
eFFECTOR Therapeutics Revenue Highlights
Main Segment (Y)
Grant Revenue
Main Geography (Y)
Grant Revenue
eFFECTOR Therapeutics Revenue by Period
eFFECTOR Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | -100.00% |
2022-12-31 | $3.55M | 148.46% |
2021-12-31 | $1.43M | -96.60% |
2020-12-31 | $42.00M | 100.00% |
2019-12-31 | - | - |
eFFECTOR Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | - | -100.00% |
2023-12-31 | $162.00K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | -100.00% |
2022-12-31 | $675.00K | -22.15% |
2022-09-30 | $867.00K | -56.89% |
2022-06-30 | $2.01M | 100.00% |
2022-03-31 | - | -100.00% |
2021-12-31 | $1.43M | 234.89% |
2021-09-30 | $427.00K | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | -100.00% |
2020-12-31 | $42.00K | -92.68% |
2020-09-30 | $574.00K | - |
eFFECTOR Therapeutics Revenue Breakdown
eFFECTOR Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 21 |
---|---|
Grant Revenue | $1.43M |
Collaboration Revenue | - |
Quarterly Revenue by Product
Product/Service | Jun 22 | Dec 21 | Sep 21 |
---|---|---|---|
D A R P A Grant | $2.00M | - | - |
Grant Revenue | - | $311.00K | $427.00K |
Collaboration Revenue | - | - | - |
eFFECTOR Therapeutics Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 21 |
---|---|
Collaboration Revenue | - |
Grant Revenue | $1.43M |
Quarterly Revenue by Country
Country | Jun 22 | Dec 21 | Sep 21 |
---|---|---|---|
D A R P A Grant | $2.00M | - | - |
Grant Revenue | - | $311.00K | $427.00K |
Collaboration Revenue | - | - | - |
EFTR Revenue FAQ
What is eFFECTOR Therapeutics’s yearly revenue?
eFFECTOR Therapeutics's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $3.55M, representing an increase of 148.46% compared to 2021. EFTR's yearly revenue for 2021 was $1.43M, representing a decrease of -96.60% compared to 2020.
What is eFFECTOR Therapeutics’s quarterly revenue?
eFFECTOR Therapeutics's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $162K, a 100.00% increase from the previous quarter (Q3 2023), and a -76.00% decrease year-over-year (Q4 2022). EFTR's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a -100.00% decrease year-over-year (Q3 2022).
What is eFFECTOR Therapeutics’s revenue growth rate?
eFFECTOR Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was 0%.
What are eFFECTOR Therapeutics’s revenue streams?
eFFECTOR Therapeutics's revenue streams in c 21 are Grant Revenue
What is eFFECTOR Therapeutics’s main source of revenue?
For the fiscal year ending Dec 21, the largest source of revenue of eFFECTOR Therapeutics was Grant Revenue. This segment made a revenue of $1.43M, representing 100.00% of the company's total revenue.